CavaGene

Curated by Signal

Provider of AI-based personalised genomic diagnostic and treatment solution

Overview

Provider of AI-based personalised genomic diagnostic and treatment solution. It offers a non-invasive home-kit and lab-based cancer diagnostics integrated with AI algorithms that detect genetic markers and anomalies indicating cancer. It offers personalised treatment recommendations based on the genetic profile.

Key facts

Founded: 2024
Headquarters: New York City, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

2 products and services: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

HealthOme
Provider of genetic test and support services for cancer
Life Sciences TechnologyHuntsville, United States
Cannabis Science
US-Based, Public, clinical-stage Biotech developing phytocannabinoid-based pharmaceuticals for critical illnesses such as cancer
Life Sciences TechnologyIrvine, United States
Lynnon Biosoft
Bioinformatic solutions
Life Sciences TechnologySan Ramon, United States

About CavaGene

What does CavaGene do?

Provider of AI-based personalised genomic diagnostic and treatment solution.

Where is CavaGene headquartered?

CavaGene is headquartered in New York City, United States.

When was CavaGene founded?

CavaGene was founded in 2024.

Which sector is CavaGene in?

CavaGene operates in Life Sciences Technology.

Who are CavaGene's competitors?

Companies similar to CavaGene include HealthOme, Cannabis Science, and Lynnon Biosoft.